Known targets — ChEMBL curated mechanism
GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Lonazolac. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 10/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.79 |
| ▸ | DRD2 | P14416 | 1/20 | 0.79 |
| ▸ | ALOX5 | P09917 | 9/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.59 |
| ▸ | CDK2 | P24941 | 2/20 | 0.59 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | AURKA | O14965 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lonazolac SCHEMBL25221 | 0.88 | KDM4E (1.00) | PTGESKDM4EDRD2ALOX5ALDH1A1 | |
| Lonazolac SCHEMBL1478078 | 0.87 | KDM4E (0.97) | PTGESKDM4EDRD2ALOX5ALDH1A1 | |
| Lonazolac SCHEMBL287156 | 0.87 | KDM4E (0.97) | PTGESKDM4EDRD2ALOX5ALDH1A1 | |
| SCHEMBL10877279 | 0.87 | KDM4E (0.83) | PTGESKDM4EDRD2ALOX5ALDH1A1 | |
| SCHEMBL3475488 | 0.86 | KDM4E (0.81) | PTGESKDM4EDRD2ALOX5ALDH1A1 | |
| SCHEMBL12608902 | 0.86 | KDM4E (0.81) | PTGESKDM4EDRD2ALOX5ALDH1A1 | |
| SCHEMBL11257500 | 0.84 | KDM4E (0.77) | PTGESKDM4EDRD2ALOX5ALDH1A1 | |
| SCHEMBL11245260 | 0.83 | KDM4E (0.90) | PTGESKDM4EDRD2ALOX5ALDH1A1 | |
| SCHEMBL11253903 | 0.83 | KDM4E (0.76) | PTGESKDM4EDRD2ALOX5ALDH1A1 | |
| SCHEMBL11166545 | 0.83 | KDM4E (0.90) | PTGESKDM4EDRD2ALOX5ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113337540-B | Model construction method for specifically knocking out Notch2 gene in mouse Treg cell | 武汉大学 | 2022-06-14 | — | — | CN | claimed |
| CN-113337540-B | Model construction method for specifically knocking out Notch2 gene in mouse Treg cell | 武汉大学 | 2022-06-14 | — | — | CN | disclosed |
| EP-0299504-A1 | A process for the preparation of 1-phenyl-3-(4-chlorophenyl)-pyrazol-4-ylacetic acid and its calcium salt | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu (CS) | 1989-01-18 | — | — | EP | disclosed |